Age-Specific Risk and Severity of Bleeding on Aspirin-based Secondary Prevention: A Population-Based Study

פריטים דומים

• Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
  מאת: Li, L, et al.
  יצא לאור: (2017)
• Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke.
  מאת: Geraghty, O, et al.
  יצא לאור: (2010)
• Aspirin in the prevention of cancer Reply
  מאת: Rothwell, P
  יצא לאור: (2011)
• Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
  מאת: Guillaume Marquis‐Gravel, et al.
  יצא לאור: (2024-02-01)
• Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.
  מאת: Marquardt, L, et al.
  יצא לאור: (2010)